The second activating glucokinase mutation (A456V): Implications for glucose homeostasis and diabetes therapy

Diabetes

Volumn 51, Issue 4, 2002, Pages 1240-1246

  Christesen, Henrik B T ^a   Jacobsen, Bendt B ^a   Odili, Stella ^b   Buettger, Carol ^b   Cuesta Munoz, Antonio ^b   Hansen, Torben ^c   Brusgaard, Klaus ^a   Massa, Ornella ^c   Magnuson, Mark A ^e   Shiota, Chiyo ^e   Matschinsky, Franz M ^b   Barbetti, Fabrizio ^d,f  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STENO DIABETES CENTER   (Denmark)

^d IBCIT Biomedical Science Park   (Italy)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHLOROTHIAZIDE; DIAZOXIDE; GLUCOKINASE; GLUCOSE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; INSULIN; PROINSULIN; RECOMBINANT ENZYME;

ADOLESCENT; ARTICLE; BODY MASS; CASE REPORT; CLINICAL FEATURE; CONVULSION; DIABETES CONTROL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIC COMA; INSULIN BLOOD LEVEL; INSULIN HYPOGLYCEMIA; INSULIN RELEASE; MALE; MATHEMATICAL MODEL; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0036227541     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.4.1240     Document Type: Article

References (38)

1. Genetics of neonatal hyperinsulinism
2. Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews
3. Adenosine diphosphate as an intracellular regulator of insulin secretion
4. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy
5. Biochemical evaluation of a patient with a familial form of leucine-sensitive hypoglycemia and concomitant hyperammonemia
6. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene
7. Hyperinsulinism-hyperammonemia syndrome caused by mutant glutamate dehydrogenase accompanied by novel enzyme kinetics
8. Familial hyperinsulinism caused by an activating glucokinase mutation
9. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes
10. Banting Lecture 1995: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm
11. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
12. Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes
13. Familial hyperglycemia due to mutations in glucokinase: Definition of a subtype of diabetes mellitus
14. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinaselinked hyperinsulinaemia (GK-HI)
15. Neonatal diabetes mellitus due to complete glucokinase deficiency
16. Two-site time-resolved immunofluorometric assay of human insulin
17. C-peptide response to glucagon: A test for the residual beta-cell function in diabetes mellitus
18. Genetic heterogeneity in familial hyperinsulinism
19. Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetes (SIEDP): High prevalence of glucokinase mutations in Italian children with MODY: Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI
20. Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme
21. Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis
22. Structural model of human glucokinase in complex with glucose and ATP: Implications for the mutants that cause hypo- and hyperglycemia
23. Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein
24. Study of the regulatory properties of glucokinase by site-directed mutagenesis: Conversion of glucokinase to an enzyme with high affinity for glucose
25. Novel pharmacological glucokinase activators enhance glucose metabolism, respiration and insulin release in isolated pancreatic islets demonstrating a unique therapeutic potential
26. Allosteric activation of islet and hepatic glucokinase: A potential new approach to diabetes therapy
27. The islands of Langerhans in 19 cases of obesity
28. Metabolic adaptation of pancreatic islet tissue in aging rats
29. Obesity and nutritional factors in the pathogenesis of non-insulin dependent diabetes mellitus
30. Animal syndromes of non-insulin dependent diabetes mellitus
31. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: Evidence for a pathogenic role of relative hyperinsulinemia
32. Abnormalities of pancreatic islets by targeted expression of a dominant-negative KATP channel
33. Hyperinsulinism of infancy: Towards an understanding of unregulated insulin release
34. Glucose regulation of glutaminolysis and its role in insulin secretion
35. Correction of diabetic alterations by glucokinase
36. Effects of increased glucokukinase gene copy number on glucose homeostasis and hepatic glucose metabolism
37. Metabolic impact of glucokinase overexpression in liver: Lowering of blood glucose in fed rats is accompanied by hyperlipidemia